The Asia Pacific Nerve Repair and Regeneration Market would witness market growth of 7.1% CAGR during the forecast period (2022-2028).
Stem cell treatment for nerve injury has a lot of potential, and it has a lot of advantages over other, more conventional therapies like surgery. It has been shown in studies to lessen overall peripheral nerve damage while also promoting tissue regeneration. This therapy may restore total functional recovery in some cases, but not all. Damage to the neurological system can be caused by a variety of factors. Diabetic patients may develop numbness as a result of neuropathy caused by long-term elevated blood sugar levels. Chemotherapy with some types of drugs can be hazardous to healthy nerve tissue. Herpes zoster is one of several viral diseases that can cause nerve damage. Finally, nerve injury is common in automobile accidents and other types of trauma.
These advancements are being achieved in peripheral nerve surgery, and a new surgical discipline including peripheral neurosurgery reconstruction is emerging. Neurosurgery, orthopaedics, hand and plastic surgery, and neurology, spinal injuries, neurophysiology, and rehabilitation medicine are just a few of the surgical disciplines involved in peripheral nerve surgery. Nerve decompression, graft reconstruction, microsurgical repair, neurolysis, and nerve transfer operations may be necessary by surgeons. When paralysis is long-term or not responsive to a main nerve treatment, tendon transfer, arthrodesis, and functioning free muscle transfers is used.
Alzheimer's disease and other kinds of dementia are becoming more common among the elderly in emerging countries, where the population is rapidly ageing. By 2020, it is anticipated that 70 percent of the world's population aged 60 and up would be residing in emerging economies, with India accounting for 14.2 percent. Only prospective incidence studies can provide accurate estimates of the rate about which new disease develops. Incidence rates of Alzheimer's disease have been found to be lower in Asian nations than in the industrialized world. Despite the availability of dementia prevalence research from Asian nations such as India, there is a scarcity of incidence data, especially from selective long-term studies.
As part of the cognitive in older adults in Trivandrum (COAT) project, researchers previously reported that the age-adjusted prevalence of dementia, including Alzheimer's disease, was 4.86 percent in a community living population in the southern Indian province of Kerala. The incidence rates of the COAT cohort after a ten-year follow-up are reported in this study. With the rising cases of these diseases and increasing R&D activities for improving nerve repair and regeneration solutions, the demand and growth of regional market would witness a spur in the coming years.
The China market dominated the Asia Pacific Nerve Repair and Regeneration Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $632.2 Million by 2028. The Japan market is anticipated to grow at a CAGR of 6.4% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 7.7% during (2022 - 2028).
Based on Surgery, the market is segmented into Neuromodulation Surgery, Direct Neuropathy, Nerve Grafting, and Stem Cell Therapy. Based on Product, the market is segmented into Neuromodulation Surgery Devices and Biomaterials. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Nerve Repair and Regeneration Market is Projected to reach USD 9.4 Billion by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Integra Lifesciences Corporation, Medtronic PLC, Axogen, Inc., Stryker Corporation, Checkpoint Surgical, Inc., Polyganics BV, Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.), and OrthoMed, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Surgery
- Neuromodulation Surgery
- Direct Neuropathy
- Nerve Grafting
- Stem Cell Therapy
By Product
- Neuromodulation Surgery Devices
- Biomaterials
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Boston Scientific Corporation
- Integra Lifesciences Corporation
- Medtronic PLC
- Axogen, Inc.
- Stryker Corporation
- Checkpoint Surgical, Inc.
- Polyganics BV
- Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
- OrthoMed, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Nerve Repair and Regeneration Market, by Surgery
1.4.2 Asia Pacific Nerve Repair and Regeneration Market, by Product
1.4.3 Asia Pacific Nerve Repair and Regeneration Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
Chapter 4. Asia Pacific Nerve Repair and Regeneration Market by Surgery
4.1 Asia Pacific Neuromodulation Surgery Market by Country
4.2 Asia Pacific Direct Neuropathy Market by Country
4.3 Asia Pacific Nerve Grafting Market by Country
4.4 Asia Pacific Stem Cell Therapy Market by Country
Chapter 5. Asia Pacific Nerve Repair and Regeneration Market by Product
5.1 Asia Pacific Neuromodulation Surgery Devices Market by Country
5.2 Asia Pacific Biomaterials Market by Country
Chapter 6. Asia Pacific Nerve Repair and Regeneration Market by Country
6.1 China Nerve Repair and Regeneration Market
6.1.1 China Nerve Repair and Regeneration Market by Surgery
6.1.2 China Nerve Repair and Regeneration Market by Product
6.2 Japan Nerve Repair and Regeneration Market
6.2.1 Japan Nerve Repair and Regeneration Market by Surgery
6.2.2 Japan Nerve Repair and Regeneration Market by Product
6.3 India Nerve Repair and Regeneration Market
6.3.1 India Nerve Repair and Regeneration Market by Surgery
6.3.2 India Nerve Repair and Regeneration Market by Product
6.4 South Korea Nerve Repair and Regeneration Market
6.4.1 South Korea Nerve Repair and Regeneration Market by Surgery
6.4.2 South Korea Nerve Repair and Regeneration Market by Product
6.5 Singapore Nerve Repair and Regeneration Market
6.5.1 Singapore Nerve Repair and Regeneration Market by Surgery
6.5.2 Singapore Nerve Repair and Regeneration Market by Product
6.6 Malaysia Nerve Repair and Regeneration Market
6.6.1 Malaysia Nerve Repair and Regeneration Market by Surgery
6.6.2 Malaysia Nerve Repair and Regeneration Market by Product
6.7 Rest of Asia Pacific Nerve Repair and Regeneration Market
6.7.1 Rest of Asia Pacific Nerve Repair and Regeneration Market by Surgery
6.7.2 Rest of Asia Pacific Nerve Repair and Regeneration Market by Product
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.2 Medtronic PLC
7.2.1 Company overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisitions and Mergers:
7.2.5.2 Approvals and Trials:
7.3 Boston Scientific Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.3.5.2 Approvals and Trials:
7.4 Integra LifeSciences Holdings Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental & Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisitions and Mergers:
7.6 Axogen, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expenses
7.6.4 Recent strategies and developments:
7.6.4.1 Approvals and Trials:
7.7 Synovis Micro Companies Alliance, Inc. (Baxter International, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.8 OrthoMed, Inc.
7.8.1 Company Overview
7.9 Polyganics BV
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Geographical Expansions:
7.10. Checkpoint Surgical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Acquisition and Mergers:
7.10.2.3 Approvals and Trials:
TABLE 1 Asia Pacific Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Nerve Repair and Regeneration Market
TABLE 4 Product Launches And Product Expansions– Nerve Repair and Regeneration Market
TABLE 5 Acquisition and Mergers– Nerve Repair and Regeneration Market
TABLE 6 Approvals and trials- Nerve Repair and Regeneration Market
TABLE 7 Geographical Expansions- Nerve Repair and Regeneration Market
TABLE 8 Asia Pacific Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 9 Asia Pacific Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 10 Asia Pacific Neuromodulation Surgery Market by Country, 2018 - 2021, USD Million
TABLE 11 Asia Pacific Neuromodulation Surgery Market by Country, 2022 - 2028, USD Million
TABLE 12 Asia Pacific Direct Neuropathy Market by Country, 2018 - 2021, USD Million
TABLE 13 Asia Pacific Direct Neuropathy Market by Country, 2022 - 2028, USD Million
TABLE 14 Asia Pacific Nerve Grafting Market by Country, 2018 - 2021, USD Million
TABLE 15 Asia Pacific Nerve Grafting Market by Country, 2022 - 2028, USD Million
TABLE 16 Asia Pacific Stem Cell Therapy Market by Country, 2018 - 2021, USD Million
TABLE 17 Asia Pacific Stem Cell Therapy Market by Country, 2022 - 2028, USD Million
TABLE 18 Asia Pacific Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 19 Asia Pacific Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 20 Asia Pacific Neuromodulation Surgery Devices Market by Country, 2018 - 2021, USD Million
TABLE 21 Asia Pacific Neuromodulation Surgery Devices Market by Country, 2022 - 2028, USD Million
TABLE 22 Asia Pacific Biomaterials Market by Country, 2018 - 2021, USD Million
TABLE 23 Asia Pacific Biomaterials Market by Country, 2022 - 2028, USD Million
TABLE 24 Asia Pacific Nerve Repair and Regeneration Market by Country, 2018 - 2021, USD Million
TABLE 25 Asia Pacific Nerve Repair and Regeneration Market by Country, 2022 - 2028, USD Million
TABLE 26 China Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 27 China Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 28 China Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 29 China Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 30 China Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 31 China Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 32 Japan Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 33 Japan Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 34 Japan Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 35 Japan Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 36 Japan Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 37 Japan Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 38 India Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 39 India Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 40 India Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 41 India Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 42 India Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 43 India Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 44 South Korea Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 45 South Korea Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 46 South Korea Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 47 South Korea Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 48 South Korea Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 49 South Korea Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 50 Singapore Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 51 Singapore Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 52 Singapore Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 53 Singapore Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 54 Singapore Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 55 Singapore Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 56 Malaysia Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 57 Malaysia Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 58 Malaysia Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 59 Malaysia Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 60 Malaysia Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 61 Malaysia Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 62 Rest of Asia Pacific Nerve Repair and Regeneration Market, 2018 - 2021, USD Million
TABLE 63 Rest of Asia Pacific Nerve Repair and Regeneration Market, 2022 - 2028, USD Million
TABLE 64 Rest of Asia Pacific Nerve Repair and Regeneration Market by Surgery, 2018 - 2021, USD Million
TABLE 65 Rest of Asia Pacific Nerve Repair and Regeneration Market by Surgery, 2022 - 2028, USD Million
TABLE 66 Rest of Asia Pacific Nerve Repair and Regeneration Market by Product, 2018 - 2021, USD Million
TABLE 67 Rest of Asia Pacific Nerve Repair and Regeneration Market by Product, 2022 - 2028, USD Million
TABLE 68 Key Information – Abbott Laboratories
TABLE 69 Key Information – Medtronic PLC
TABLE 70 key Information – Boston Scientific Corporation
TABLE 71 Key Information – Integra LifeSciences Holdings Corporation
TABLE 72 key Information – Stryker Corporation
TABLE 73 Key Information – Axogen, Inc.
TABLE 74 Key Information – Synovis Micro Companies Alliance, Inc.
TABLE 75 Key Information – OrthoMed, Inc
TABLE 76 Key Information – Polyganics BV
TABLE 77 Key Information – Checkpoint Surgical Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Recent strategies and developments: Abbott Laboratories
FIG 5 Recent strategies and developments: Integra Lifesciences Corporation
FIG 6 Recent strategies and developments: Polyganics BV
FIG 7 Recent strategies and developments: Checkpoint Surgical, Inc.